Showing results (651-660 of 902) with videos related to

Sort By:
Pageof 91
The Journal of Allergy and Clinical Immunology|December 22, 2014
Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescenceMarit Westman, Christian Lupinek, Jean Bousquet, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 12, 2025
A novel approach to consider Planetary Health in guideline development: a GRADE approach using the Allergic Rhinitis and its Impact on Asthma (ARIA) 2024-2025 guidelines as a case-studyRafael José Vieira, Bernardo Sousa-Pinto, Alina Herrmann, et al.
Plant Physiology|October 29, 2014
Insights into conifer giga-genomesAmanda R De La Torre, Inanc Birol, Jean Bousquet, et al.
International Archives of Allergy and Immunology|November 28, 2012
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of MonacoG Walter Canonica, Carlos E Baena-Cagnani, Enrico Compalati, et al.
The Journal of Allergy and Clinical Immunology|July 29, 2016
Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: The EGEA studyValérie Siroux, Christian Lupinek, Yvonne Resch, et al.
Plos One|July 1, 2020
Describing the status of reproductive ageing simply and precisely: A reproductive ageing score based on three questions and validated with hormone levelsKai Triebner, Ane Johannessen, Cecilie Svanes, et al.
Clinical and Translational Allergy|November 1, 2012
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapyMoises A Calderon, Pascal Demoly, Roy Gerth van Wijk, et al.
Allergy|September 2, 2020
Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched modelCristoforo Incorvaia, Mona Al-Ahmad, Ignacio J Ansotegui, et al.
Allergy|October 15, 2021
Receptor binding domain-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 outbreaksHubert Blain, Edouard Tuaillon, Lucie Gamon, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2002
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trialSven-Erik Dahlén, Kerstin Malmström, Ewa Nizankowska, et al.
Pageof 91